| |
Latest 10 SEC filings (by transaction date) for AKRO within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 3/24 | Apr 1/24 | Young Jonathan | Direct Ownership | Common Stoek | S - Open market or private sale | -400 | $25.03 |
Apr 3/24 | Apr 1/24 | Young Jonathan | Direct Ownership | Common Stock | S - Open market or private sale | -4,600 | $24.33 |
Mar 15/24 | Mar 13/24 | Yale Catriona | Direct Ownership | Common Stock | S - Open market or private sale | -723 | $28.33 |
Mar 15/24 | Mar 13/24 | White William Richard | Direct Ownership | Common Stock | S - Open market or private sale | -724 | $28.33 |
Mar 15/24 | Mar 13/24 | Cheng Andrew | Direct Ownership | Common Stock | S - Open market or private sale | -1,969 | $28.33 |
Mar 15/24 | Mar 13/24 | Young Jonathan | Direct Ownership | Common Stock | S - Open market or private sale | -651 | $28.33 |
Mar 15/24 | Mar 13/24 | Rolph Timothy | Direct Ownership | Common Stock | S - Open market or private sale | -619 | $28.33 |
Mar 6/24 | Mar 4/24 | Cheng Andrew | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -57,733 | |
Mar 6/24 | Mar 4/24 | Cheng Andrew | Direct Ownership | Common Stock | S - Open market or private sale | -114 | $36.28 |
Mar 6/24 | Mar 4/24 | Cheng Andrew | Direct Ownership | Common Stock | S - Open market or private sale | -7,995 | $35.49 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for AKRO within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 3/24 | Apr 1/24 | Young Jonathan | Direct Ownership | Common Stoek | S - Open market or private sale | -400 | $25.03 |
Apr 3/24 | Apr 1/24 | Young Jonathan | Direct Ownership | Common Stock | S - Open market or private sale | -4,600 | $24.33 |
Mar 15/24 | Mar 13/24 | Yale Catriona | Direct Ownership | Common Stock | S - Open market or private sale | -723 | $28.33 |
Mar 15/24 | Mar 13/24 | White William Richard | Direct Ownership | Common Stock | S - Open market or private sale | -724 | $28.33 |
Mar 15/24 | Mar 13/24 | Cheng Andrew | Direct Ownership | Common Stock | S - Open market or private sale | -1,969 | $28.33 |
Mar 15/24 | Mar 13/24 | Young Jonathan | Direct Ownership | Common Stock | S - Open market or private sale | -651 | $28.33 |
Mar 15/24 | Mar 13/24 | Rolph Timothy | Direct Ownership | Common Stock | S - Open market or private sale | -619 | $28.33 |
Mar 6/24 | Mar 4/24 | Cheng Andrew | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -57,733 | |
Mar 6/24 | Mar 4/24 | Cheng Andrew | Direct Ownership | Common Stock | S - Open market or private sale | -114 | $36.28 |
Mar 6/24 | Mar 4/24 | Cheng Andrew | Direct Ownership | Common Stock | S - Open market or private sale | -7,995 | $35.49 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |